Corabotase clinical trials
Also written IPN10200.
How each study uses corabotase is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the corabotase studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
6 studies that test it; most in 2026 (3)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 3 |
Who runs them
Industry 6 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 5, 2 in phase 3
Studies that test corabotase, phase 3 first.
- Dec 2026A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the EyebrowsPhase 3 · Ipsen
- Dec 2026A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the EyebrowsPhase 3 · Ipsen
- Mar 2027A Study of IPN10200 for the Treatment of Cervical Dystonia in AdultsPhase 2 · Ipsen
- Aug 2027A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial LinesPhase 1/2 · Ipsen
- Oct 2027A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in AdultsPhase 2 · Ipsen
Studies
Open first, then newest update. How each study uses corabotase is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Study to Assess the Effectiveness and Safety of IPN10200 in Adult Chinese Participants With Moderate to Severe Wrinkle-like Lines Between the EyebrowsRecruitingPhase 3IpsenNCT07779252Written as Corabotase
- A Study of IPN10200 for the Treatment of Cervical Dystonia in AdultsRecruitingPhase 2IpsenNCT06937931Written as Corabotase
- A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial LinesActive, not recruitingPhase 1/2IpsenNCT04821089Written as Corabotase
- A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the EyebrowsActive, not recruitingPhase 3IpsenNCT07435428Written as Corabotase
- A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the EyebrowsActive, not recruitingPhase 3IpsenNCT07427797Written as Corabotase
- A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in AdultsActive, not recruitingPhase 2IpsenNCT06625060Written as Corabotase
Given beside what is tested · 1 — corabotase is usual care or a partner of the new treatment
Codes
What other systems call corabotase · ClinicalTrials.gg INT015623
- UNII (FDA) 88GMN9FF3BCORABOTASEOne source FDA
- NCI Thesaurus C216015CorabotaseOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 88GMN9FF3B | CORABOTASE | One source FDA |
| NCI Thesaurus | C216015 | Corabotase | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.